Zensar Technologies Ltd
Zensar Technologies Surges 7.5% in a Day - Is This the Start of a Strong Comeback ?

Zensar Technologies Ltd. gained 7.49% on July 3, 2026, significantly outperforming both the broader market and the IT sector. The rally extended the stock's three-day winning streak to over 17%, supported by improving short-term technical momentum. However, despite the sharp rebound, the stock continues to trade below key long-term resistance levels, leaving investors questioning whether this marks the beginning of a sustained recovery or merely a temporary relief rally.
Zensar Technologies emerged as one of the strongest performers during the session, climbing 7.49% to an intraday high of ₹498.80. While the Sensex gained only 0.61%, Zensar outperformed its sector by more than five percentage points, indicating that the buying interest was largely stock-specific rather than being driven by the broader market. The stock also opened with a strong gap-up and has now advanced more than 17% over the past three trading sessions, reflecting a noticeable improvement in short-term investor sentiment. From a technical perspective, the stock has moved above its 5-day, 20-day and 50-day moving averages, signalling improving near-term momentum. However, it continues to trade below its 100-day and 200-day moving averages, which remain important resistance levels for confirming a long-term trend reversal. This suggests that while buyers have regained control in the short term, the broader recovery is still in its early stages and requires further confirmation through sustained price strength. Despite the recent rally, Zensar's longer-term performance remains under pressure. The stock is still down nearly 29% on a year-to-date basis and has declined more than 41% over the past year, substantially underperforming the broader market. Although recent gains have helped recover part of these losses, investors remain cautious as the stock has yet to establish a consistent long-term uptrend.
Most technical indicators continue to present a mixed picture. Weekly and monthly MACD indicators remain in bearish territory, while Bollinger Bands also indicate that the broader trend has not yet turned positive. Volume-based indicators have improved only modestly, suggesting that stronger institutional participation may still be required to sustain the rally. While short-term momentum has clearly strengthened, the technical setup currently supports the view of a recovery attempt rather than a confirmed breakout. The next few trading sessions will be crucial for Zensar Technologies. A sustained move above its 100-day and 200-day moving averages, supported by stronger trading volumes, would strengthen the case for a broader trend reversal. Until then, the recent 7.5% surge appears to represent an encouraging recovery from oversold levels, but investors may look for additional confirmation before concluding that a new long-term uptrend has begun.
Latest News
Tata Power expands renewable portfolio with Maharashtra wind project commissioning
Tata Power Renewable Energy has commissioned a 100.8 MW wind project in Maharashtra, adding to its growing clean energy portfolio. The project enhances renewable power supply for Mumbai while supporting the group's long-term decarbonisation strategy.
3:37 pm
3 July 2026
Max Estates delivers sharp presales growth as residential pipeline gathers momentum
Max Estates reported a strong start to FY27 with pre-sales rising more than fivefold year-on-year, driven by a successful residential launch and sustained demand across existing projects. Alongside a fully leased commercial portfolio, the company enters the year with a sizeable development pipeline that could support future growth.
2:51 pm
3 July 2026
Raymond Realty delivers strong first quarter sales momentum despite no new launches
Raymond Realty reported a sharp rise in first-quarter pre-sales and collections, supported by healthy demand across its Mumbai Metropolitan Region projects. The performance highlights strong execution, although borrowings remain elevated due to ongoing project development.
2:27 pm
3 July 2026
Zydus expands precision oncology reach through Apollo Hospitals partnership
Zydus Lifesciences has partnered with Apollo Hospitals to expand access to its Shield™ multi-cancer detection blood test across India. The collaboration strengthens the company's precision oncology strategy while supporting wider adoption of early cancer screening technologies.
1:27 pm
3 July 2026
IRB Infra secures long term implementation contracts from IRB InvIT
IRB Infrastructure Developers has approved project implementation agreements worth about ₹2,663 crore with IRB InvIT Fund for two operational highway projects. The long-duration contracts improve revenue visibility and reinforce the company's asset management and operations business.
_edited.png)